Objective: Obesity is an independent cardiovascular risk factor, but its prognostic role in patients with peripheral arterial disease (PAD) is not well defined. Accordingly, we assessed the impact of body mass index (BMI) and waist circumference (WC) on cardiovascular risk in a homogeneous cohort of PAD patients. Methods: BMI and WC were measured in 190 consecutive PAD patients with ABI o0.90, referred to our university hospital for intermittent claudication. The occurrence of cardiac, cerebrovascular and peripheral events was prospectively assessed. The ability to classify risk was determined by calculating the hazard ratios (HRs) and c-statistics. Results: During a median follow-up of 31.5 months, 63 patients (33.2%) had a cardiovascular event. Considered as continuous variables, both adiposity indices were significantly associated with increased cardiovascular risk, even after adjustment for possible confounding factors (HR ¼ 1.08, 95% CI 1.01-1.15, P ¼ 0.045 for BMI and HR ¼ 1.04, 95% CI 1.01-1.07, P ¼ 0.004 for WC). When BMI and WC were included together in a fully adjusted Cox model, the significant association between BMI and cardiovascular risk disappeared (HR ¼ 0.98, 95% CI 0.88-1.10, P ¼ 0.772), whereas WC remained significantly associated with a worse outcome (HR ¼ 1.04, 95% CI 1.01-1.08, P ¼ 0.033). The better discriminative ability of WC vs BMI was confirmed by the c-statistic, which was significantly higher for WC (0.63, 95% CI 0.56-0.70) than for BMI (0.56, 95% CI 0.51-0.63, P ¼ 0.038). Conclusions: Abdominal obesity and, to a lesser degree, general obesity worsen the prognosis of PAD patients independently of possible confounding factors. Weight reduction should be integrated in the active management of these patients.
Introduction
Obesity is a recognized independent cardiovascular risk factor in the general population, [1] [2] [3] [4] but its role in patients with established cardiovascular disease is not well defined. [5] [6] [7] [8] [9] Furthermore, it is not clear what measure of adiposity best predicts the occurrence of cardiovascular events, 10, 11 and controversy exists about and the impact of body fat distribution on outcome. 3, 4, 9 In the Physician's Heath Study, 3 Gelber et al. observed that cardiovascular risk increased linearly and significantly with higher levels of all adiposity indices, that is, body mass index (BMI), waist circumference (WC), waist-to-hip ratio and waist-to-height ratio. In particular, the authors did not find substantial differences between cardiovascular risk assessment obtained with BMI and that obtained with other measures. Conversely, Canoy et al. 4 found that indices of abdominal adiposity, in particular waist-to-hip ratio, were more consistently and strongly predictive of coronary artery disease than BMI. Finally, in the RICO study, 9 WC as a continuous variable did not have any impact on the prediction of death after myocardial infarction (MI), whereas increased BMI was associated with reduced death rate (the 'obesity paradox'). However, this negative relationship disappeared after adjustment for baseline predictors of death, thus leading to the conclusion that, neither BMI nor WC independently predicted death after MI. Therefore, many studies have investigated the relationship between obesity and cardiovascular risk, but the prospective value of the various adiposity measures remains to be clarified. Peripheral arterial disease (PAD), which affects about 27 million persons in Europe and the US, 12 is another major manifestation of atherosclerosis, and entails a very high incidence of ischemic events. [13] [14] [15] Obesity, which is associated with inflammation and metabolic syndrome, 16, 17 conditions portending a worse outcome in PAD, [18] [19] [20] [21] may be particularly detrimental for cardiovascular risk in affected individuals. Nevertheless, very few studies have investigated the relationship between obesity and occurrence of cardiovascular events in PAD; moreover, with conflicting results. [21] [22] [23] [24] This prompted us to conduct a prospective study aimed at evaluating the prognostic impact of obesity in a homogeneous cohort of PAD patients. Furthermore, as no study of obesity in PAD investigated the joint and independent effects of general and abdominal obesity, the secondary aim of our study was to compare the predictive value of BMI (an index of general obesity) and WC (an index of abdominal obesity).
Materials and methods

Patients
Between July 2004 and July 2006, 190 consecutive patients referring to our vascular laboratory with a history of intermittent claudication for at least one year entered the study. The diagnosis of PAD was based on ankle brachial index (ABI) o0.90 associated with one or more stenoses of the lower-extremity arteries at B-mode ultrasound. ABI was measured after participants had rested supine for 5 min. A Doppler probe was used to measure the systolic pressure in the brachial, dorsalis pedis and posterior tibial arteries. The lower ABI of the two legs was used as a predictor of future cardiovascular events. Claudicants with ABI 41.40 were excluded because these values may be falsely elevated due to severe arterial calcification. Other exclusion criteria were recent (o 6 months) coronary or peripheral revascularization procedures, recent (o 6 months) unstable angina, MI or stroke, decompensated heart failure, malignant neoplasia and clinically significant hepatic or renal disease. All women were postmenopausal and none was receiving hormone replacement therapy. Participants gave written, informed consent to the study, which was approved by our institutional ethics committee. X88 cm for women and X102 cm for men were the cut-offs used to diagnose central obesity. 26 All anthropometric measurement were made by the same physician in the morning.
Definitions
Assessment of cardiovascular events
Patients were contacted for follow-up at 3-month intervals. Twelve patients did not regularly attend our outpatient clinic and their follow-up data were obtained by telephone interviews. The minimum follow-up period was 6 months. The occurrence of cardiac (fatal and non-fatal MI, unstable angina and coronary revascularization procedures), cerebrovascular (fatal and non-fatal ischemic stroke, transient ischemic attack and carotid surgery) and peripheral (critical limb ischemia (that is, pain at rest or trophic lesions) or revascularization procedures of the lower limbs) events was prospectively assessed. A secondary outcome of interest was the occurrence of all the above-mentioned cardiovascular events with the exception of peripheral events. Medical records and death certificates of all patients who had an event were obtained and validated by a cardiologist unaware of the patient's obesity status. For patients who had more than one event, only the first was considered for analysis.
Statistical analysis
Variables are expressed as mean ± s.d., or n (%), and comparisons were made by t-test for unpaired samples or w 2 -test, as appropriate. Correlation between BMI and WC was evaluated by the Pearson test. Cox-proportional hazard analyses, using BMI and WC as continuous variables, were performed to test the association of general and central obesity with cardiovascular events. In the adjusted model, the following covariates that are known to be potential contributors of outcome were included: age, sex, smoking, diabetes mellitus, hypercholesterolemia, hypertension and occurrence of previous MI or previous stroke. Another adjusted Cox model included ABI as well. Finally, in a fully adjusted model BMI and WC were included together.
Kaplan-Meier survival curves were used to estimate the cumulative event rates in patients with general obesity (BMI X30 kg m
À2
) and abdominal obesity (WC X88 for women and X102 cm for men). Probability values were then calculated with log-rank test and hazard ratios (HRs) by Cox analyses.
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The ability to classify risk of BMI and WC was assessed by using the c-statistic, as HRs for BMI and WC are not directly comparable and, mainly, because c-statistic measures discrimination ability better than HR. 27, 28 Comparison between the c-statistics was made by pairwise comparison of ROC curves.
All statistical tests were two-sided. For all tests, a P-value o0.05 was considered statistically significant. Statistical analyses were performed using SPSS 12.0 (SPSS Inc., Chicago, IL, USA). 29 was lower in obese than in non-obese patients, thus representing a potential strong confounding factor. However, in the Cox model adjusted even for ABI, both adiposity indices remained significantly associated with the risk of future cardiovascular Of note, the significant associations of BMI and WC with cardiovascular events remained substantially unmodified also when the 11 peripheral events were excluded from the analyses (data not shown).
Results
Patients
Kaplan-Meier survival curves depicting the incidence of cardiovascular events in obese vs non-obese patients are presented in Figures 1 and 2 Obesity and peripheral arterial disease G Giugliano et al obesity (WC X88/102 cm) had a 2.59-fold increased risk (95% CI 1.47-4.54) compared with patients without this diagnosis. The results remained substantially unmodified when peripheral events were excluded from the analyses (Figures 1 and 2 ).
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Discussion
Here we report, for the first time, the prognostic impact of two adiposity measures in a prospective cohort of PAD subjects. We found that both BMI and WC were linearly associated with the risk of incident cardiovascular events in PAD. Our findings remained practically unchanged after accounting for multiple confounders, which suggests that increased risk may not be related solely to conditions linked to obesity, such as diabetes, hypertension and hypercholesterolemia. The results remained unchanged also after adjustment for ABI, which is, to date, the most powerful prognostic indicator in PAD, 29 and, which, in our population, was significantly lower in obese patients. However, when both BMI and WC were included together in the multivariate analyses, only the latter maintained a significant association with outcome. Furthermore, the c-statistic for WC was significantly higher than that for BMI. This indicates that, at least in PAD, despite the high correlation existing between the two indices, WC was more consistently and strongly predictive of cardiovascular risk than BMI. However, as pointed out by Litwin, 30 'clinical practicability is frequently overshadowed by statistical significance'. Actually, in our study, Kaplan-Meier curves showed that, compared with BMI, the difference in cardiovascular risk assessment using WC was small and likely not clinically consequential. Nevertheless, pathophysiological findings associated with fat distribution may concur to explain why, in PAD, WC could be a stronger predictor of cardiovascular risk as compared with BMI. In effect, the risk of comorbidity development depends on the severity of obesity, but even more on body composition and fat mass distribution. The major cardiovascular risk is linked to abdominal partitioning of fat, and mainly to visceral localization of adipose tissue. 31, 32 Indeed, unlike peripheral fat, visceral adipocytes are responsible for production and secretion of many cytokines and substances that can promote atherosclerosis. 33 Furthermore, abdominal obesity is also associated with lower levels of adiponectin, a vascular protective substance. 34 Therefore, the overwhelming action of the pro-vs antiatherosclerotic effect of abdominal obesity may be responsible for the fact that WC shows a greater prognostic impact on outcome as compared with BMI. Additionally, PAD is more common in the elderly, in whom BMI may be a poor measure of body fat. 35, 36 Indeed, the measurement of weight does not differentiate between fat and fat-free mass, and fat-free mass is progressively lost with increasing age. inverse relationship between BMI and cardiovascular mortality, which is consistent with the so-called obesity paradox that has been observed in subjects with multiple atherosclerotic risk factors, patients with heart failure, and those with coronary artery disease. 7, 8, 38 Consistently, in a non-homogeneous population of 2302 patients who underwent major vascular surgery (lower-limb revascularization procedures, carotid endarterectomy or abdominal aortic surgery), Galal et al. 24 found that the higher the BMI, the lower the mortality rate. However, when the authors adjusted for the presence of chronic obstructive pulmonary disease, the inverse relationship was lost. This suggests that the obesity paradox observed in this series of vascular surgery patients was essentially due to the high prevalence of chronic obstructive pulmonary disease in non-obese patients.
Clinical implications
Obesity seems to be less prevalent among PAD patients than among patients with other atherosclerotic vascular diseases and this could be due, at least in part, to the higher prevalence of smoking among affected individuals. 39 However, in the REACH registry, 39 the prevalence of abdominal obesity in PAD patients was as high as 44.1% and that of general obesity was 23.8%Fpercentages only slightly lower than in coronary or cerebrovascular disease patients, which confirm the considerable burden of this condition also in PAD. Therefore, the fact that, in our study, obesity was associated with an increased incidence of cardiovascular events in PAD suggests that it would be of critical importance to incorporate the measurement of BMI and/or WC in the physical examination of affected individuals. This assessment could guide appropriate strategies to reduce obesity ) should receive counselling for weight reduction by inducing negative caloric balance with reduction of caloric intake, carbohydrate restriction and increased exercise. The results of our study, coupled with the scarce attention for the prognostic value of obesity in PAD, suggest the need for further studies to assess (1) the effect of different diets on body fat composition, (2) which type of exercise is more efficient to reduce obesity (taking into account the physical limitations of claudicants) and (3) whether weight reduction, and, especially, visceral fat reduction, improves the outcome.
Study limitations and strengths
Our results cannot be extended to all patients with PAD because we enrolled only patient with intermittent claudication. Therefore, further studies are needed to evaluate the prognostic impact of BMI and WC especially in patients with asymptomatic disease (stage-I of Fontaine's classification) who represent the majority of PAD population and whose cardiovascular risk is not much lower than that of claudicants. 42 Furthermore, the anthropometric measurement were taken at a single time point, and we have no information on previous or subsequent measurements, other than a simple question about unexplained weight loss. Finally, our results are based on simple anthropometric indices, and we had no direct measure of body fat or muscle composition. However, weight, height and WC were not selfreported, but measured directly by the same physician. Other important strengths are the prospective design of the study and confirmation of incident events after medical record review. Finally, because a high HR for a marker in relation to a disease outcome does not necessarily indicate a better predictive performance, 43 another strength of our study is that we compared the prognostic value of BMI and WC using the c-statistic, which measures discrimination ability better than HR does.
27,28
Conclusions
This study suggests that abdominal obesity and, to a lesser degree, general obesity worsen the prognosis of patients with PAD, independently of possible confounding factors. Should these findings be confirmed in larger prospective studies, weight reduction will probably have to be considered in the active management of these patients. However, the impact of this management on the prognosis of PAD patients awaits further evaluation.
